INS and obesity due to melanocortin 4 receptor deficiency: The latest research shows that SCFAs can not only effectively reduce the incidence of enteritis, cardiovascular disease, colon cancer, obesity and diabetes, but also play an important role in maintaining the balance of energy metabolism (mainly glucose metabolism) and increasing insulin tolerance (Delzenne and Cani, 2005; Delzenne et al., 2011).